GlassScriptPhysician profile
Laura D Connor
NPI 1619268620
$10,514.75
in general payments reported to CMS, 2019-2025
32 companies · $2,865 in 2025
The $2,865 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $279 · 2021: $753 · 2022: $1,409 · 2023: $1,801 · 2024: $2,460 · 2025: $2,865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,048 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,048.48 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,528.95 | 2019-2025 | Skyrizi, Linzess, Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,417.91 | 2019-2025 | Xifaxan, Plenvu, Relistor |
| Janssen Biotech, INC. | $1,004.06 | 2019-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $708.53 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Celgene Corporation | $622.56 | 2021-2024 | Zeposia |
| Pfizer INC. | $408.15 | 2019-2025 | |
| Madrigal Pharmaceuticals | $380.78 | 2024-2025 | Rezdiffra |
| Genzyme Corporation | $354.13 | 2023-2025 | |
| Ironwood Pharmaceuticals, INC | $287.79 | 2019-2024 | Linzess |
| Lilly USA, LLC | $266.82 | 2024-2025 | Omvoh |
| Ardelyx, INC. | $262.22 | 2023-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $258.90 | 2023-2025 | Dupixent |
| Gilead Sciences, INC. | $192.29 | 2019-2024 | Epclusa |
| Qol Medical, LLC | $155.83 | 2019-2025 | Sucraid |
| Phathom Pharmaceuticals, INC. | $112.54 | 2024-2025 | Voquezna |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $72.60 | 2025 | Wegovy |
| Ipsen Biopharmaceuticals, INC | $71.82 | 2024-2025 | Iqirvo |
| Intercept Pharmaceuticals, INC. | $67.01 | 2021-2025 | |
| Amgen INC. | $65.98 | 2025 | Uplizna |
| Aimmune Therapeutics, INC. | $38.42 | 2023-2024 | |
| Allergan, INC. | $36.05 | 2019 | |
| Capsovision, INC. | $34.52 | 2024 | Capsocam Plus |
| Braintree Laboratories, INC. | $30.50 | 2023 | Sutab, Suflave |
| Micro-Tech Endoscopy USA, INC. | $17.33 | 2025 | Lesionhunter |
| Daiichi Sankyo INC. | $16.46 | 2019 | |
| Fresenius Kabi USA, LLC | $16.31 | 2024 | Idacio |
| Ferring Pharmaceuticals INC. | $15.69 | 2023 | Rebyota |
| Sandoz INC. | $15.33 | 2023 | Hyrimoz |
| Shire North American Group INC | $14.09 | 2019 | |
| Evoke Pharma, INC. | $14.00 | 2025 | |
| Olympus America INC. | $13.64 | 2019 | |
| Merck Sharp & Dohme LLC | $13.54 | 2024 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Connor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.